Evidence map›Paper›PMID 40330365›Full record

ArticleCureus2025

Right Ventricular Perforation and Cardiac Tamponade Post-FlowTriever® System Treatment in High-Risk Pulmonary Embolism: A Rare Complication.

David Casasola-González, Leyre Alonso-Gonzalo, Tatiana Pire-García, Pablo Demelo-Rodríguez, Sergio Moragón-Ledesma, Rubén Alonso-Beato, Jorge García-Carreño, María Eugenia Vázquez-Álvarez, Lucía Ordieres-Ortega, Francisco Galeano-Valle

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

David Casasola-GonzálezVenous Thromboembolism Unit, Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, ESP.
Leyre Alonso-GonzaloVenous Thromboembolism Unit, Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, ESP.
Tatiana Pire-GarcíaVenous Thromboembolism Unit, Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, ESP.
Pablo Demelo-RodríguezVenous Thromboembolism Unit, Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, ESP.
Sergio Moragón-LedesmaVenous Thromboembolism Unit, Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, ESP.
Rubén Alonso-BeatoVenous Thromboembolism Unit, Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, ESP.
Jorge García-CarreñoDepartment of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, ESP.
María Eugenia Vázquez-ÁlvarezDepartment of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, ESP.
Lucía Ordieres-OrtegaVenous Thromboembolism Unit, Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, ESP.
Francisco Galeano-ValleVenous Thromboembolism Unit, Department of Internal Medicine, Hospital General Universitario Gregorio Marañón, Madrid, ESP.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Catheter-directed thrombectomy (CDT) using the FlowTriever® system offers promising results and could represent a paradigm shift in reducing morbidity and mortality of patients with intermediate-high and high-risk acute pulmonary embolism (PE). However, it is crucial to be aware of the risks and limitations associated with this technique. We present an extremely rare case of a 44-year-old male patient diagnosed with cerebral venous thrombosis of the transverse and sigmoid venous sinuses complicated by hemorrhagic lesions, who developed a high-risk PE within 24 hours of admission. Due to concomitant contraindications for anticoagulation in a patient with intracranial hemorrhage, the FlowTriever® system was chosen as the preferred intervention despite its associated risks. CDT was performed, provoking right ventricular perforation and cardiac tamponade immediately after the procedure. Only one previous case has been reported describing this extremely rare complication following FlowTriever® CDT. We reviewed the literature on indications, efficacy, and safety of this procedure, as well as our experience with this technique in patients with intermediate-high- and high-risk PE, clarifying whether prior reports included only FlowTriever® or other CDT devices. Additionally, we discuss the clinical implications of this case, highlighting the importance of careful patient selection when considering CDT in high-risk PE cases with contraindications for anticoagulation.

Indexed as

catheter-directed thrombectomyflowtriever® systempercutaneous mechanical thrombectomypulmonary embolismright ventricular perforation

Identifiers

PMID40330365
PMCPMC12054599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.